Adverse Drug Reactions and Drug Safety

Monitoring adverse drug reactions (ADRs) is essential for ensuring drug safety. ADRs, ranging from mild effects to severe toxicity, can result from drug interactions, genetic factors, or dosage errors. Pharmacovigilance systems have evolved to track ADRs post-marketing, enabling early detection of risks. Personalized medicine, through pharmacogenomics, improves drug safety by predicting individual responses to therapies, minimizing ADRs, and optimizing treatment. Regulatory frameworks also play a crucial role in maintaining drug safety.

    Related Conference of Adverse Drug Reactions and Drug Safety

    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 18-19, 2025

    13th World Congress and Expo on Green Energy

    Valencia, Spain
    August 21-22, 2025

    20th World Convention on Waste Recycling and Reuse

    Paris, France
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France
    September 19-20, 2025

    7th World Congress on Environmental Toxicology and Chemistry

    Aix-en-Provence, France
    September 22-23, 2025

    17th World Congress and Expo on Recycling

    Dubai, UAE
    October 06-07, 2025

    5th World Congress on Climate Change and Ecosystem

    Paris, France
    October 06-07, 2025

    7th Global Summit on Environmental Health

    Paris, France
    October 27-28, 2025

    19th Global Summit and Expo on Biomass and Bioenergy

    London, UK
    November 13-14, 2025

    14th World Conference on Earth Science & Geology

    Paris, France
    November 13-14, 2025

    19th World Congress on Biofuels and Bioenergy

    Paris, France
    November 20-21, 2025

    14th International Conference on Climate Change & Environmental Science

    London, UK

    Adverse Drug Reactions and Drug Safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in